Takemura K - Search Results

1

Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma.

Hamada K, Fujiwara R, Takemura K, Komai Y, Oguchi T, Numao N, Yamamoto S, Yonese J, Yuasa T. Hamada K, et al. Among authors: takemura k. Int J Urol. 2022 Oct;29(10):1181-1187. doi: 10.1111/iju.14964. Epub 2022 Jun 18. Int J Urol. 2022. PMID: 35717138

2

Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients.

Suzuki H, Ito M, Takemura K, Nakanishi Y, Kataoka M, Sakamoto K, Tobisu KI, Koga F. Suzuki H, et al. Among authors: takemura k. Urol Oncol. 2020 Mar;38(3):76.e11-76.e17. doi: 10.1016/j.urolonc.2019.10.014. Epub 2019 Dec 19. Urol Oncol. 2020. PMID: 31864938

3

Impact of Serum γ-Glutamyltransferase on Overall Survival in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy.

Takemura K, Yuasa T, Inamura K, Amori G, Koga F, Board PG, Yonese J. Takemura K, et al. Target Oncol. 2020 Jun;15(3):347-356. doi: 10.1007/s11523-020-00719-9. Target Oncol. 2020. PMID: 32474759

4

Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab after Failure of Prior Tyrosine Kinase Inhibitors.

Takemura K, Yuasa T, Fujiwara R, Ito M, Suzuki H, Yonese J, Koga F. Takemura K, et al. J Urol. 2020 Dec;204(6):1166-1172. doi: 10.1097/JU.0000000000001196. Epub 2020 Jun 22. J Urol. 2020. PMID: 32567459

5

Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab.

Fujiwara R, Takemura K, Fujiwara M, Yuasa T, Yasuoka S, Komai Y, Numao N, Yamamoto S, Yonese J. Fujiwara R, et al. Among authors: takemura k. Clin Genitourin Cancer. 2021 Apr;19(2):e78-e83. doi: 10.1016/j.clgc.2020.10.007. Epub 2020 Nov 10. Clin Genitourin Cancer. 2021. PMID: 33279413

6

Prognostic significance of the controlling nutritional status score in patients with metastatic renal cell carcinoma diagnosed before an era of first-line immune-oncology combination therapies.

Sekiya K, Ito M, Takemura K, Suzuki H, Kobayashi S, Koga F. Sekiya K, et al. Among authors: takemura k. Jpn J Clin Oncol. 2021 Oct 5;51(10):1570-1576. doi: 10.1093/jjco/hyab078. Jpn J Clin Oncol. 2021. PMID: 34075403

7

Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel.

Une M, Takemura K, Inamura K, Fukushima H, Ito M, Kobayashi S, Yuasa T, Yonese J, Board PG, Koga F. Une M, et al. Among authors: takemura k. Cancers (Basel). 2021 Nov 8;13(21):5587. doi: 10.3390/cancers13215587. Cancers (Basel). 2021. PMID: 34771748 Free PMC article.

8

Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma.

Kobayashi S, Ito M, Takemura K, Suzuki H, Yonese I, Koga F. Kobayashi S, et al. Among authors: takemura k. Int J Clin Oncol. 2022 Mar;27(3):574-584. doi: 10.1007/s10147-021-02088-3. Epub 2021 Dec 3. Int J Clin Oncol. 2022. PMID: 34860315

9

Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.

Navani V, Ernst M, Wells JC, Yuasa T, Takemura K, Donskov F, Basappa NS, Schmidt A, Pal SK, Meza L, Wood LA, Ernst DS, Szabados B, Powles T, McKay RR, Weickhardt A, Suarez C, Kapoor A, Lee JL, Choueiri TK, Heng DYC. Navani V, et al. Among authors: takemura k. JAMA Netw Open. 2022 Jun 1;5(6):e2216379. doi: 10.1001/jamanetworkopen.2022.16379. JAMA Netw Open. 2022. PMID: 35687336 Free PMC article.

10

Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.

Takemura K, Navani V, Ernst MS, Wells JC, Meza L, Pal SK, Lee JL, Li H, Agarwal N, Alva AS, Hansen AR, Basappa NS, Szabados B, Powles T, Tran B, Hocking CM, Beuselinck B, Yuasa T, Choueiri TK, Heng DYC. Takemura K, et al. J Urol. 2023 Apr;209(4):701-709. doi: 10.1097/JU.0000000000003132. Epub 2022 Dec 27. J Urol. 2023. PMID: 36573926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page